A Study to Evaluate Investigation Drug, BHV-7000, in Patients with Refractory Focal Onset Epilepsy
Purpose
This research is being done to see the effectiveness and safety of a new drug called BHV-7000 as a possible treatment for focal seizures for patients who are taking anti-seizure medications (ASMs) and still experiencing seizures. Refractory focal epilepsy is when someone continues to have focal seizures despite treatment with ASMs or other treatments.
People who take part in this study will be randomly assigned to either study medication or a placebo, will participate for up to 5 months, and the study includes up to 7 in-person visits.
Could this study be right for you?
1. Experiencing at least 4 or more observable focal seizures per month
2. Taking at least 1 and up to 3 anti-seizure medications
3. Do not have a history of cluster/repetitive seizures (which you were not able to individually count) in the past 6 months
4. Between the ages of 18 to 75